Orion Portfolio Solutions LLC lowered its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 21.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,954 shares of the company's stock after selling 10,812 shares during the quarter. Orion Portfolio Solutions LLC's holdings in GE HealthCare Technologies were worth $3,124,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also bought and sold shares of the company. CoreFirst Bank & Trust purchased a new position in shares of GE HealthCare Technologies in the fourth quarter worth about $25,000. Runnymede Capital Advisors Inc. purchased a new stake in GE HealthCare Technologies during the 4th quarter valued at about $28,000. Continuum Advisory LLC grew its position in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock worth $31,000 after acquiring an additional 168 shares during the last quarter. Bank of Jackson Hole Trust purchased a new position in GE HealthCare Technologies in the 4th quarter worth approximately $32,000. Finally, OFI Invest Asset Management bought a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $34,000. Hedge funds and other institutional investors own 82.06% of the company's stock.
Wall Street Analysts Forecast Growth
GEHC has been the topic of several recent analyst reports. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and raised their price target for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. Finally, Wells Fargo & Company increased their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $97.73.
Get Our Latest Research Report on GEHC
GE HealthCare Technologies Stock Down 16.0 %
Shares of GEHC stock traded down $11.49 during midday trading on Friday, reaching $60.51. 16,885,304 shares of the stock were exchanged, compared to its average volume of 3,023,599. GE HealthCare Technologies Inc. has a 1 year low of $58.04 and a 1 year high of $94.80. The firm has a market cap of $27.67 billion, a PE ratio of 13.97, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The company's 50 day moving average is $85.41 and its two-hundred day moving average is $85.43. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion for the quarter, compared to analysts' expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.
GE HealthCare Technologies Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.23%. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.23%.
About GE HealthCare Technologies
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
See Also

Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.